Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Healthtrust
QuintilesIMS
US Army
Citi
AstraZeneca
Harvard Business School
Argus Health
Fuji
Merck

Generated: August 16, 2017

DrugPatentWatch Database Preview

Adenosine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for adenosine and what is the scope of adenosine patent protection?

Adenosine
is the generic ingredient in three branded drugs marketed by West-ward Pharms Int, Luitpold, Sagent Strides, Emcure Pharms Ltd, Wockhardt, Teva Pharms Usa, Fresenius Kabi Usa, Astellas, Mylan Labs Ltd, Akorn, Gland Pharma Ltd, and Hospira Inc, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for adenosine. Sixteen suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: adenosine

Tradenames:3
Patents:0
Applicants:12
NDAs:19
Drug Master File Entries: see list26
Suppliers / Packagers: see list16
Bulk Api Vendors: see list95
Clinical Trials: see list365
Patent Applications: see list9,661
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:adenosine at DailyMed

Pharmacology for Ingredient: adenosine

Tentative approvals for ADENOSINE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe3MG/MLINJECTABLE; INJECTION
► Subscribe► Subscribe3MG/MLINJECTABLE; INJECTION
► Subscribe► Subscribe3MG/MLINJECTABLE; INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
ADENOSINE
adenosine
SOLUTION;IV (INFUSION)203883-002Mar 24, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Astellas
ADENOSCAN
adenosine
SOLUTION;IV (INFUSION)020059-002May 18, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
ADENOSINE
adenosine
INJECTABLE;INJECTION078686-001May 13, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Astellas
ADENOCARD
adenosine
INJECTABLE;INJECTION019937-002Oct 30, 1989APRXYesYes► Subscribe► Subscribe► Subscribe
Akorn
ADENOSINE
adenosine
INJECTABLE;INJECTION078076-001Oct 31, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: adenosine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astellas
ADENOCARD
adenosine
INJECTABLE;INJECTION019937-002Oct 30, 1989► Subscribe► Subscribe
Astellas
ADENOSCAN
adenosine
SOLUTION;IV (INFUSION)020059-001May 18, 1995► Subscribe► Subscribe
Astellas
ADENOSCAN
adenosine
SOLUTION;IV (INFUSION)020059-001May 18, 1995► Subscribe► Subscribe
Astellas
ADENOSCAN
adenosine
SOLUTION;IV (INFUSION)020059-002May 18, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Fuji
Cantor Fitzgerald
Accenture
QuintilesIMS
AstraZeneca
Cerilliant
Daiichi Sankyo
Chubb
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot